bioAffinity Technologies
BIAFW
3 hedge funds and large institutions have $43.3K invested in bioAffinity Technologies in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0.53% less ownership
Funds ownership: 8.34% → 7.81% (-0.53%)
8% less capital invested
Capital invested by funds: $47.1K → $43.3K (-$3.83K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.53K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$400 |
| 3 |
CS
Clear Street
New York
|
-$100 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
1
Clear Street
New York
| $19.3K | -$100 | -279 | -0.5% |
|
|
2
UBS Group
Zurich,
Switzerland
| $16.3K | -$400 | -1,120 | -2% |
|
|
3
Citadel Advisors
Miami,
Florida
| $7.75K | -$2.53K | -7,086 | -23% |
|
BIAFW Hedge Fund Activity: Q4 2025 in Review
3 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAFW) for Q4 2025, worth a combined $43.3K — down 8.1% from $47.1K a quarter earlier.
Fund positioning in BIAFW was balanced in Q4 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 3 trimmed.
The largest seller was Citadel Advisors, cutting an estimated $2.53K.
- 3 institutional investors held bioAffinity Technologies (BIAFW) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $43.3K of bioAffinity Technologies stock for Q4 2025, down 8.1% quarter-over-quarter.
- 0 funds opened new bioAffinity Technologies positions in Q4 2025 and 0 closed out.
- The largest bioAffinity Technologies seller in Q4 2025 was Citadel Advisors, an estimated $2.53K sold.
Based on aggregated 13F filings for Q4 2025.